Tumor Immunity and Cancer Recurrence Prediction Model

Launched by ANHUI PROVINCIAL HOSPITAL · Feb 27, 2025

Keywords

ClinConnect Summary

This clinical trial, titled "Tumor Immunity and Cancer Recurrence Prediction Model," is exploring a new scoring system called TIMES, which aims to predict whether cancer might come back after patients have had surgery to remove their tumors. The researchers want to find out how accurate this scoring system is in determining the likelihood of cancer recurrence in patients who have undergone surgery for different types of cancer, such as liver, lung, gastric, or colorectal cancer.

To participate in this study, you need to be an adult (18 years or older) who has been diagnosed with cancer and is eligible for surgery. It's important that you are not pregnant or breastfeeding and that you are not planning to become pregnant in the next two years. Participants will be monitored for up to 10 years after their surgery to see how their condition progresses. The information used for the study comes from tissue samples taken after surgery, which will not harm the participants' health. If you decide to join the study, you will be fully informed about what it involves and will need to sign a consent form agreeing to participate.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria：
• • 1.Adult males and females (non-pregnant, non-lactating)； 2.18 years or older (inclusive); 3.Diagnosis: Diagnosed with cancer (e.g., liver cancer, lung cancer, gastric cancer, colorectal cancer, etc.) and eligible for surgical resection; 4.Informed Consent: Participants must be fully informed about the study prior to participation and voluntarily sign a written informed consent form;
• • Exclusion Criteria：
• • 1. Specimens from pregnant or lactating patients will not be included in this study, and participant should have no plans for pregnancy or lactation within the next 2 years.
• • 2. Participants must be at least 18 years old.